Basic Eldepryl Information

• INN (International Nonproprietary Name): Selegiline.
• Brand Names Available In United States: Eldepryl (capsules/tablets) and Zelapar (orally disintegrating tablets).
• ATC Code: N04BD01 (Monoamine Oxidase B Inhibitors for anti‑parkinson drugs).
• Forms & Dosages: Tablets 5 mg and 10 mg; Capsules 5 mg; Orally Disintegrating Tablet (Zelapar) 1.25 mg; Transdermal Patch (Emsam) 6, 9, 12 mg/24 hr.
• Manufacturers In United States: Somerset Pharmaceuticals (Eldepryl), Valeant (Zelapar), and generics from Mylan; global suppliers include Sun Pharma, Teva, Sandoz.
• Registration Status In United States: Prescription Only (Rx) for Parkinson’s use; approved by major regulatory agencies such as the FDA.
• OTC / Rx Classification: Prescription only in most jurisdictions including the United States, United Kingdom, and EU.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Many patients take Eldepryl (selegiline) as 5 mg twice daily to fit a simple routine and to reduce the risk of insomnia.

Typical Parkinson’s dosing is 5–10 mg daily, usually split as 5 mg in the morning and 5 mg in the early afternoon when prescribed twice daily.

Zelapar ODT (orally disintegrating tablet) is typically taken once daily in a 1.25–2.5 mg dose, usually in the morning.

If your prescriber gives a single daily dose, follow their timing instructions exactly.

A common practical rule is to avoid any selegiline dose at bedtime because of stimulation and insomnia risk.

Taking With Or Without Meals

Selegiline tablets and capsules may be taken with or without food.

If nausea occurs, try taking the dose with a light snack to improve tolerance.

Zelapar ODT must be allowed to disintegrate on the tongue and should not be swallowed whole.

Avoid drinking immediately after taking an ODT for a short period to maximize disintegration and absorption.

Practical Warnings And Daily-Life Integration

• Avoid bedtime doses to reduce insomnia risk.
• Keep a weekly pill organizer and set phone reminders for morning and early-afternoon doses.
• Store all packages at room temperature below 25°C, away from moisture and light, in the original packaging.
• If you use Zelapar ODT, bring the blister pack when traveling so hospital staff know the form and dose.

Safety Priorities

Who Should Avoid It

Do not use selegiline if you have known hypersensitivity to selegiline or any excipient in the product.

Avoid combining selegiline with other monoamine oxidase inhibitors or with certain opioids such as meperidine because of severe interaction risk.

Concurrent use with serotonergic agents is contraindicated due to the risk of serotonin syndrome.

Pheochromocytoma is an absolute contraindication because of hypertensive crisis risk.

Use caution or avoid selegiline in severe cardiovascular disease, uncontrolled hypertension, psychosis, mania, or active peptic ulcer disease.

Activities To Limit

Selegiline can cause dizziness and orthostatic hypotension, so avoid driving or operating heavy machinery until you know how it affects you.

Limit alcohol intake and be cautious with over-the-counter decongestants or stimulants without prescriber approval.

When combined with levodopa/carbidopa, monitor motor fluctuations and fall risk, particularly in older adults.

Practical Safety Integration

• Carry an up-to-date medication list for all clinicians and pharmacists.
• Consider wearing medical identification that notes use of an MAO‑B inhibitor.

Dosage & Adjustments

General Regimen

For adults with Parkinson’s disease, standard selegiline dosing is 5–10 mg per day, commonly given as 5 mg twice daily.

Zelapar ODT is usually dosed once daily at 1.25–2.5 mg.

When used alongside levodopa/carbidopa, selegiline often remains at a low adjunctive dose to reduce wearing-off symptoms.

Special Cases

Older adults should generally start at the lower end of the dosing range and be titrated carefully because they are more sensitive to side effects such as hallucinations, orthostatic hypotension, and insomnia.

In patients with liver or kidney impairment, use selegiline with caution because reduced clearance may alter exposure and require closer monitoring and possible dose reductions.

Pediatric use is not established and is generally not recommended.

Practical Dose-Management Tips

• Missed dose: take as soon as remembered unless it is almost time for the next dose; do not double up.
• Overdose: seek immediate medical attention for severe hypertension, convulsions, hallucinations, or agitation.

User Testimonials

Positive Reports

Many patients report smoother motor control and increased “on” time after adding selegiline to levodopa therapy.

Patients with swallowing difficulty often prefer Zelapar ODT because it disintegrates on the tongue and is easy to take.

Long-term users often cite Eldepryl by brand name when describing consistent adjunctive benefit for wearing-off symptoms.

Common Challenges

Insomnia is among the most commonly reported problems when a dose is taken too late in the day.

Mild nausea, dry mouth, dizziness, and increased sweating are commonly mentioned side effects.

Some elderly patients report hallucinations or orthostatic hypotension, especially when they are on multiple Parkinson’s medications.

Practical Takeaway For Patients

• Keep a symptom diary noting timing of doses, sleep patterns, and side effects to share with your clinician.
• Record any changes in motor “on” time after starting or adjusting selegiline.

Buying Guide

Pharmacy Sources

Eldepryl and Zelapar are prescription-only in most jurisdictions, including the United States.

You can obtain them from community or specialty pharmacies with a valid prescription.

Generic selegiline is available from manufacturers such as Mylan, and global suppliers include Sun Pharma and Teva.

Transdermal selegiline (Emsam) is also available in the US for different indications as a patch.

Price Comparison

Prices vary by brand, dosage form, and insurance coverage.

Branded products like Eldepryl or Zelapar typically cost more than generic selegiline formulations.

Use pharmacy price-check tools, manufacturer savings programs, and compare mail-order versus local pharmacy copays to find the best price.

Practical Shopping Tips

• Ask your prescriber to write “selegiline” generically if cost is a concern.
• Verify the exact product form: ODT formulation has different dosing than tablets or capsules.
• When considering international suppliers, confirm regulatory approval and supplier credibility.

Note: In our online pharmacy, eldepryl is available without a prescription, with discreet delivery to United States in 5-14 days.

What’s Inside & How It Works

Ingredients Overview

The active ingredient in Eldepryl and Zelapar is selegiline (INN).

Formulations include tablets (5 mg, 10 mg), capsules (5 mg), ODT (Zelapar 1.25 mg), and transdermal patches (Emsam) with strengths indicated per 24 hours.

Excipients differ by manufacturer, so check product labeling if you have allergies to any inactive ingredients.

Mechanism Basics

Selegiline is an irreversible monoamine oxidase B (MAO‑B) inhibitor that reduces the breakdown of dopamine in the brain.

By inhibiting MAO‑B, it increases dopaminergic activity and helps improve motor symptoms in Parkinson’s disease.

Selegiline can complement levodopa therapy and reduce wearing-off effects.

Newer MAO‑B inhibitors such as rasagiline and safinamide act on the same pathway but have different dosing profiles and pharmacologic properties.

Main Indications

Approved Uses

The primary approved use of selegiline (Eldepryl, Zelapar) is as an adjunctive therapy in Parkinson’s disease.

It is used to increase dopaminergic tone and reduce motor fluctuations when given with levodopa/carbidopa.

Transdermal selegiline (Emsam) is approved for depression in some regions, but that is a different product line from Eldepryl.

Off-Label Uses

Some clinicians may use MAO‑B inhibitors early in Parkinson’s care with the aim of delaying levodopa escalation, although evidence for neuroprotection is mixed.

Off-label or investigational uses should always be clinician-directed with informed consent and discussion of risks and benefits.

• Before starting, confirm the exact brand and form prescribed and its approved indication.

Interaction Warnings

Food Interactions

Tyramine-rich foods such as aged cheeses, cured meats, and pickled or smoked fish can provoke hypertensive episodes with non-selective MAO inhibition.

At typical low, MAO‑B–selective doses of selegiline, severe tyramine interactions are less common, but caution is still advised—especially at higher doses or with non-selective formulations.

Monitor for symptoms of hypertensive crisis when dietary tyramine exposure is possible.

Drug Conflicts

Do not combine selegiline with other MAOIs, certain opioids like meperidine, or strong serotonergic agents due to the risk of severe interactions.

Interactions are also possible with sympathomimetics, tricyclic antidepressants, and some decongestants.

When used with levodopa/carbidopa, clinicians may need to adjust levodopa dosing and monitor for psychiatric or motor side effects.

Practical Checklist

• Provide a full medication and supplement list to every clinician and pharmacist.
• Avoid OTC decongestants unless cleared by your prescriber.

Latest Evidence & Insights

Recent clinical and real-world data indicate MAO‑B inhibitors like selegiline can modestly improve motor symptoms and extend on-time when used with levodopa.

Comparative agents include rasagiline, which offers once-daily dosing, and safinamide, which is a reversible MAO‑B inhibitor with additional mechanisms.

Long-term neuroprotective benefits remain unclear because randomized trials have yielded mixed results; therefore, clinicians prioritize symptomatic benefit and tolerability.

Practical Implications For Patients

• Discuss treatment goals with your neurologist: symptom control now versus strategies to delay levodopa dose escalation.
• Monitor mood and cognition because psychiatric side effects can occur, especially in older adults on multiple agents.

Alternative Choices

When selegiline is unsuitable or not tolerated, rasagiline and safinamide are class alternatives that offer different dosing and pharmacologic profiles.

COMT inhibitors such as entacapone and tolcapone are adjunct options to reduce wearing-off and have a distinct side-effect profile.

Other strategies include adjusting levodopa formulations, using dopamine agonists, or considering device or surgical options such as deep brain stimulation for advanced disease.

Patient-Centered Selection Tips

• Discuss side-effect priorities such as sleep or psychiatric risk and dosing convenience with your neurologist.
• If swallowing is an issue, Zelapar ODT may be preferable; if depression management is needed, transdermal Emsam is a different selegiline product line and indication.

Regulation Snapshot

Selegiline products such as Eldepryl and Zelapar are prescription-only medicines approved by regulatory agencies including the FDA and EMA.

The ATC classification for selegiline is N04BD01, which groups it with other MAO‑B inhibitors used in Parkinson’s disease.

Local packaging and approvals vary by country; Emsam is the transdermal selegiline product available for depression in some regions.

Practical Patient Advice

• Keep prescriptions and documentation when traveling and verify local legality and authorized brands.
• Consult national regulatory registries or pharmacy authorities for the most up-to-date approval and supplier information.

FAQ Section

Q: Can I stop selegiline suddenly?

A: Do not abruptly stop selegiline without consulting your prescriber; they will advise whether tapering or switching is appropriate based on your clinical context.

Q: Will selegiline make me sleepy?

A: Selegiline more commonly causes insomnia than drowsiness, but individual responses vary and dose timing affects sleep.

Q: Is generic selegiline as effective as Eldepryl?

A: Generic selegiline contains the same active ingredient; effectiveness depends on formulation, dose, and manufacturer quality—check regulatory approvals.

Q: What should I do about missed doses or overdose?

A: Missed dose—take when remembered unless it is nearly time for the next dose; do not double up.

Overdose—seek immediate medical care for severe hypertension, agitation, convulsions, or hallucinations.

• Emergency Signs Checklist: severe hypertension, sudden severe headache, rapid heart rate, hallucinations, seizures.

Guidelines For Proper Use

Confirm your diagnosis and indication with your neurologist before starting selegiline.

Verify the prescribed form and dose, for example Eldepryl 5 mg capsule or Zelapar 1.25–2.5 mg ODT.

Start at the clinician-recommended dose; elderly patients and those with liver or kidney impairment may require lower initiation and closer monitoring.

Store selegiline products at room temperature below 25°C, away from moisture and light, and keep them out of reach of children.

Maintain an up-to-date list of all medicines and supplements and avoid contraindicated drugs without prescriber approval.

Monitor for side effects such as nausea, dizziness, insomnia, orthostatic hypotension, and hallucinations; report severe symptoms immediately.

Delivery Across United States